Feedback / Questions
CHS-0214 (etanercept biosimilar) - Coherus
Baxter: Investor Conference
(Baxter)
-
May 24, 2015 -
Anticipated loss of exclusivity in US in Q4 2028
Commercial
•
Biosimilar
http://investor.baxter.com/phoenix.zhtml?c=86121&p=irol-presentations
May 24, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.